Soliqua 100/33 and Heart attack - a phase IV clinical study of FDA data

Summary:

Heart attack is reported as a side effect among people who take Soliqua 100/33 (insulin glargine; lixisenatide), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Aspirin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Heart attack when taking Soliqua 100/33. It is created by eHealthMe based on reports of 2,760 people who have side effects when taking Soliqua 100/33 from the FDA, and is updated regularly.

What is Soliqua 100/33?

Soliqua 100/33 has active ingredients of insulin glargine; lixisenatide. eHealthMe is studying from 2,765 Soliqua 100/33 users. Check the latest studies of Soliqua 100/33.

What is Heart attack?

Heart attack is found to be associated with 2,488 drugs and 3,297 conditions by eHealthMe. Check the latest studies of Heart attack.

On Jul, 08, 2026

2,760 people reported to have side effects when taking Soliqua 100/33.
Among them, 11 people (0.4%) have Heart attack.

Could Soliqua 100/33 cause Heart attack?

Among these 11 people:

How long have people been on Soliqua 100/33 when they have Heart attack? *

What is the gender of people who have Heart attack when taking Soliqua 100/33? *

female: 50 %
male: 50 %

What is the age of people who have Heart attack when taking Soliqua 100/33? *

What are other drugs people take besides Soliqua 100/33? *

Steglatro: 1 person, 9.09%
Spironolactone: 1 person, 9.09%
Plavix: 1 person, 9.09%
Metformin Hydrochloride: 1 person, 9.09%
Lantus Solostar: 1 person, 9.09%
Lantus: 1 person, 9.09%
Cozaar: 1 person, 9.09%
Atorvastatin Calcium: 1 person, 9.09%
Aspirin: 1 person, 9.09%

What are other side effects people have besides Heart attack? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 4 people, 36.36%
Blood Glucose Increased: 3 people, 27.27%
Memory Loss: 3 people, 27.27%
Muscle Function Loss: 2 people, 18.18%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 2 people, 18.18%
Weight Decreased: 1 person, 9.09%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 9.09%
Agitation (state of anxiety or nervous excitement): 1 person, 9.09%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 9.09%
Atherosclerosis (disorder of the arteries): 1 person, 9.09%

What are the existing conditions these people have? *

Type 2 Diabetes: 4 people, 36.36%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 9.09%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Soliqua 100/33 and have Heart attack?

- Check whether Heart attack is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Soliqua 100/33:

Soliqua 100/33 (2,765 reports)

Heart attack treatments and more:

Heart attack (266,145 reports)

How severe was Heart attack and when was it recovered:

Heart attack in Soliqua 100/33

Expand to all the drugs that have ingredients of insulin glargine; lixisenatide:

Heart attack and drugs with ingredients of insulin glargine; lixisenatide

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Soliqua 100/33:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart attack:

Heart attack (2,488 drugs)

Browse all the conditions that are associated with Heart attack:

Heart attack (3,297 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin glargine; lixisenatide (the active ingredients of Soliqua 100/33) and Soliqua 100/33 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.